Larry L. Wood - 12 Jul 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
12 Jul 2021
Net transactions value
-$565,978
Form type
4
Filing time
12 Jul 2021, 19:37:38 UTC
Previous filing
14 Jun 2021
Next filing
10 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $275,590 +7,830 +2.1% $35.20 379,964 12 Jul 2021 Direct F1
transaction EW Common Stock Sale $841,568 -7,830 -2.1% $107.48 372,134 12 Jul 2021 Direct F1
holding EW Common Stock 496 12 Jul 2021 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7,830 -17% $0.000000 39,150 12 Jul 2021 Common Stock 7,830 $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.